HeartSciences (HSCS) Financial Statements & Analysis

HeartSciences (HSCS) Income Statement

HeartSciences reported revenue of $4.32K in fiscal 2026 (fiscal year ended Apr 30, 2026), down 0.7% from $4.35K a year earlier. HeartSciences posted a net loss of $9.14M, compared with a net loss of $8.77M a year earlier. Gross margin was 59.1% and operating margin -194787.4%. In the most recent quarter, Q1 fiscal 2027 (ended Jul 31, 2026), revenue was $2.10K, up 10.5% from the same quarter a year earlier.

HeartSciences Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

HeartSciences Inc. income statement - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Apr 2026	Apr 2025	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.02	0.01	0.01	0.03	0.06
Cost of Revenue	0.00	0.00	0.01	0.00	0.01	0.04	0.11
Gross Profit	0.00	0.00	0.01	0.00	0.01	-0.02	-0.05
Operating Expenses
Research & Development	2.84	4.39	2.88	2.46	3.00	1.71	2.04
Selling, General & Administrative	5.58	3.97	3.44	3.65	1.71	0.84	1.73
Operating Expenses	8.42	8.36	6.32	6.12	4.72	2.55	3.77
Operating Income	-8.41	-8.35	-6.31	-6.11	-4.71	-2.57	-3.82
Other Income/Expense
Interest Income	0.00	0.09	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.75	-0.50	0.35	-0.24	0.37	0.13	0.00
Other Income/Expense	-0.73	-0.41	0.05	-0.24	0.25	0.12	0.01
Income
Income Before Tax	-9.14	-8.77	-6.61	-6.35	-4.83	-2.45	-3.81
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Income	-9.14	-8.77	-6.61	-6.35	-4.83	-2.45	-3.81
Net Income - Continuous Operations	-9.14	-8.77	-6.61	-6.35	-4.83	-2.45	-3.81
Net Income - Discontinued Operations	-	-	-	-	-	-	-
EBITDA	-8.39	-8.31	-6.16	-6.09	-4.43	-2.29	-3.74
EBIT	-8.41	-8.35	-6.25	-6.11	-4.46	-2.57	-
Depreciation & Amortization	0.13	0.04	0.10	0.03	0.03	0.03	0.06
Earnings Per Share
Basic EPS	-3.00	-9.00	-19.00	-80.00	-60.00	-78.00	-116.00
Diluted EPS	-3.00	-9.00	-19.00	-5.00	-60.00	-78.00	-116.00
Basic Shares Outstanding	2.63	0.94	0.35	0.08	0.08	0.03	0.03
Diluted Shares Outstanding	2.63	0.94	0.35	0.08	0.08	0.03	0.03

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About HeartSciences Financial Statements

What was HeartSciences's revenue in fiscal 2026?

HeartSciences reported revenue of $4.32K in fiscal 2026 (fiscal year ended Apr 30, 2026). That was down 0.7% from $4.35K a year earlier.

Is HeartSciences profitable?

No. HeartSciences reported a net loss of $9.14M in fiscal 2026. In fiscal 2025 it lost $8.77M.

What is HeartSciences's operating margin?

HeartSciences's operating income was −$8.41M on revenue of $4.32K in fiscal 2026, an operating margin of -194787.4%, compared with -192013.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition